SOX2 and neoplasm: Taking together, these results indicate that iadademstant inhibited CSC-driven mammosphere formation efficiency through suppressing LSD1/SOX2 axis in a luminal-B breast carcinoma, whereas the size of mammospheres in a luminal-A tumor was regulated through other underlying proliferative mechanism via LSD1.